• レポートコード:D0JU09032 • 出版社/出版日:Transparency Market Research / 2020年2月13日 • レポート形態:英文、PDF、211ページ • 納品方法:Eメール • 産業分類:医療機器 |
Single User | ¥608,475 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥923,475 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,238,475 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、心血管および軟部組織修復パッチの世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、市場概要、製品別(合成パッチ、生物学的パッチ[異種パッチ、同種パッチ])分析、用途別(心血管修復[心臓再建および血管再建]、軟部組織修復[腹壁再建、胸壁再建、硬膜再建、ヘルニア修復、その他])分析、エンドユーザー別(病院、外来手術センター、専門クリニック)分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・市場概要 ・心血管および軟部組織修復パッチの世界市場:製品別(合成パッチ、生物学的パッチ[異種パッチ、同種パッチ]) ・心血管および軟部組織修復パッチの世界市場:用途別(心血管修復[心臓再建および血管再建]、軟部組織修復[腹壁再建、胸壁再建、硬膜再建、ヘルニア修復、その他]) ・心血管および軟部組織修復パッチの世界市場:エンドユーザー別(病院、外来手術センター、専門クリニック) ・心血管および軟部組織修復パッチの世界市場:地域別 ・競争状況 |
Cardiovascular & Soft Tissue Repair Patch Market – Scope of the Report
TMR’s report on the global cardiovascular & soft tissue repair patch market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global cardiovascular & soft tissue repair patch market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiovascular & soft tissue repair patch market during the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiovascular and soft tissue repair patch market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiovascular and soft tissue repair patch market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global cardiovascular and soft tissue repair patch market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiovascular and soft tissue repair patch market.
The report delves into the competitive landscape of the global cardiovascular and soft tissue repair patch market. Key players operating in the global cardiovascular & soft tissue repair patch market are identified, and each one of these is profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiovascular & soft tissue repair patch market that have been profiled in this report.
Key Questions Answered in Cardiovascular & Soft Tissue Repair Patch Market Report
What is the scope of growth of product companies in the global cardiovascular & soft tissue repair patch market?
What will be the Y-o-Y growth of the global cardiovascular & soft tissue repair patch market between 2019 and 2027?
What is the influence of changing trends in technologies on the global cardiovascular & soft tissue repair patch market?
Will North America continue to be the most profitable regional market for cardiovascular & soft tissue repair patch providers?
Which factors will hamper the growth of the global cardiovascular & soft tissue repair patch market during the forecast period?
Which are the leading companies in the global cardiovascular & soft tissue repair patch market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct a comprehensive research on the global cardiovascular and soft tissue repair patch market, and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global cardiovascular & soft tissue repair patch market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global cardiovascular & soft tissue repair patch market as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from the cardiovascular & soft tissue repair patch market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global cardiovascular & soft tissue repair patch market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on growth prospects of the global cardiovascular & soft tissue repair patch market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiovascular & Soft Tissue Repair Patch Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Key Industry Events (product launch and approval, key merger & acquisition, etc.)
5.2. Overview of Cardiovascular and Soft Tissue Repair Patch
5.3. Epidemiology of Cardiovascular Diseases, Soft Tissue Injury, Dural Injuries, Peripheral Injuries, by Region/Country
6. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Synthetic Patch
6.3.2. Biologic Patch
6.3.2.1. Xenogeneic Patch
6.3.2.2. Allogeneic Patch
6.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Product
7. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
7.3.1. Cardiovascular Repair
7.3.1.1. Cardiac Reconstruction
7.3.1.2. Vascular Reconstruction
7.3.2. Soft Tissue Repair
7.3.2.1. Abdominal Wall Reconstruction
7.3.2.2. Thoracic Wall Reconstruction
7.3.2.3. Dural Reconstruction
7.3.2.4. Hernia Repair
7.3.2.5. Others
7.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Application
8. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialty Clinics
8.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by End-user
9. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Country/Region
10. North America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
10.2.1. Synthetic Patch
10.2.2. Biologic Patch
10.2.2.1. Xenogeneic Patch
10.2.2.2. Allogeneic Patch
10.3. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
10.3.1. Cardiovascular Repair
10.3.1.1. Cardiac Reconstruction
10.3.1.2. Vascular Reconstruction
10.3.2. Soft Tissue Repair
10.3.2.1. Abdominal Wall Reconstruction
10.3.2.2. Thoracic Wall Reconstruction
10.3.2.3. Dural Reconstruction
10.3.2.4. Hernia Repair
10.3.2.5. Others
10.4. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialty Clinics
10.5. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
11.2.1. Synthetic Patch
11.2.2. Biologic Patch
11.2.2.1. Xenogeneic Patch
11.2.2.2. Allogeneic Patch
11.3. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
11.3.1. Cardiovascular Repair
11.3.1.1. Cardiac Reconstruction
11.3.1.2. Vascular Reconstruction
11.3.2. Soft Tissue Repair
11.3.2.1. Abdominal Wall Reconstruction
11.3.2.2. Thoracic Wall Reconstruction
11.3.2.3. Dural Reconstruction
11.3.2.4. Hernia Repair
11.3.2.5. Others
11.4. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialty Clinics
11.5. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
12.2.1. Synthetic Patch
12.2.2. Biologic Patch
12.2.2.1. Xenogeneic Patch
12.2.2.2. Allogeneic Patch
12.3. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
12.3.1. Cardiovascular Repair
12.3.1.1. Cardiac Reconstruction
12.3.1.2. Vascular Reconstruction
12.3.2. Soft Tissue Repair
12.3.2.1. Abdominal Wall Reconstruction
12.3.2.2. Thoracic Wall Reconstruction
12.3.2.3. Dural Reconstruction
12.3.2.4. Hernia Repair
12.3.2.5. Others
12.4. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialty Clinics
12.5. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
13.2.1. Synthetic Patch
13.2.2. Biologic Patch
13.2.2.1. Xenogeneic Patch
13.2.2.2. Allogeneic Patch
13.3. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
13.3.1. Cardiovascular Repair
13.3.1.1. Cardiac Reconstruction
13.3.1.2. Vascular Reconstruction
13.3.2. Soft Tissue Repair
13.3.2.1. Abdominal Wall Reconstruction
13.3.2.2. Thoracic Wall Reconstruction
13.3.2.3. Dural Reconstruction
13.3.2.4. Hernia Repair
13.3.2.5. Others
13.4. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialty Clinics
13.5. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
14.2.1. Synthetic Patch
14.2.2. Biologic Patch
14.2.2.1. Xenogeneic Patch
14.2.2.2. Allogeneic Patch
14.3. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
14.3.1. Cardiovascular Repair
14.3.1.1. Cardiac Reconstruction
14.3.1.2. Vascular Reconstruction
14.3.2. Soft Tissue Repair
14.3.2.1. Abdominal Wall Reconstruction
14.3.2.2. Thoracic Wall Reconstruction
14.3.2.3. Dural Reconstruction
14.3.2.4. Hernia Repair
14.3.2.5. Others
14.4. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialty Clinics
14.5. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis/Ranking, by Company, 2018
15.3. Company Profiles
15.3.1. W. L. Gore & Associates, Inc.
15.3.1.1. Company Overview
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. BD
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Edwards Lifesciences Corporation
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. CryoLife, Inc.
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Baxter International, Inc.
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Johnson & Johnson (Medical Devices Business Services, Inc.)
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Aesculap, Inc. (a B. Braun company)
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Nurami Medical Nanofiber Technology
15.3.8.1. Company Overview
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Medtronic
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. FOC Medical S.A.
15.3.10.1. Company Overview
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Medprin Regenerative Medical Technologies Co., Ltd.
15.3.11.1. Company Overview
15.3.11.2. Growth Strategies
15.3.11.3. SWOT Analysis
15.3.12. CorMatrix, Inc.
15.3.12.1. Company Overview
15.3.12.2. Growth Strategies
15.3.12.3. SWOT Analysis
15.3.13. Terumo Corporation
15.3.13.1. Company Overview
15.3.13.2. Company Financials
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis
15.3.14. Lamed GmbH
15.3.14.1. Company Overview
15.3.14.2. Growth Strategies
15.3.14.3. SWOT Analysis
15.3.15. South America Implants S.A.
15.3.15.1. Company Overview
15.3.15.2. Growth Strategies
15.3.15.3. SWOT Analysis
List of TablesTable 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 04: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 09: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 10: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 12: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 13: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 15: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 16: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 17: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 19: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 20: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 24: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 25: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 26: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 27: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 29: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 30: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 31: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 32: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 33: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 34: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 35: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 37: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 38: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 39: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 40: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 41: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 42: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027